CA2316405A1 - Modulation de l'inflammation a l'aide de produits du type protease - Google Patents
Modulation de l'inflammation a l'aide de produits du type protease Download PDFInfo
- Publication number
- CA2316405A1 CA2316405A1 CA002316405A CA2316405A CA2316405A1 CA 2316405 A1 CA2316405 A1 CA 2316405A1 CA 002316405 A CA002316405 A CA 002316405A CA 2316405 A CA2316405 A CA 2316405A CA 2316405 A1 CA2316405 A1 CA 2316405A1
- Authority
- CA
- Canada
- Prior art keywords
- mcp
- cells
- host
- gelatinise
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002316405A CA2316405A1 (fr) | 2000-05-26 | 2000-08-17 | Modulation de l'inflammation a l'aide de produits du type protease |
PCT/CA2001/000741 WO2001090361A2 (fr) | 2000-05-26 | 2001-05-25 | Modulation des effets de protease sur des substrats de chimiokines |
AU2001261971A AU2001261971A1 (en) | 2000-05-26 | 2001-05-25 | Modulation of inflammation by protease-treated mcp-3 chemokine |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2307705 CA2307705A1 (fr) | 2000-05-26 | 2000-05-26 | Modulation de l'inflammation a l'aide de produits du type protease |
CA2,307,705 | 2000-05-26 | ||
CA002316405A CA2316405A1 (fr) | 2000-05-26 | 2000-08-17 | Modulation de l'inflammation a l'aide de produits du type protease |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2316405A1 true CA2316405A1 (fr) | 2001-11-26 |
Family
ID=25681785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002316405A Abandoned CA2316405A1 (fr) | 2000-05-26 | 2000-08-17 | Modulation de l'inflammation a l'aide de produits du type protease |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001261971A1 (fr) |
CA (1) | CA2316405A1 (fr) |
WO (1) | WO2001090361A2 (fr) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998006751A1 (fr) * | 1996-08-16 | 1998-02-19 | Research Corporation Technologies, Inc. | Antagonistes des recepteurs de mcp-3, rantes et mip-1alpha |
EP0906954A1 (fr) * | 1997-09-29 | 1999-04-07 | Applied Research Systems ARS Holding N.V. | C-C chémokine tronquée à l'aminoterminus comme antagoniste de chémokines |
-
2000
- 2000-08-17 CA CA002316405A patent/CA2316405A1/fr not_active Abandoned
-
2001
- 2001-05-25 AU AU2001261971A patent/AU2001261971A1/en not_active Abandoned
- 2001-05-25 WO PCT/CA2001/000741 patent/WO2001090361A2/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU2001261971A1 (en) | 2001-12-03 |
WO2001090361A2 (fr) | 2001-11-29 |
WO2001090361A3 (fr) | 2002-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1061944B1 (fr) | Antagonistes therapeutiques du recepteur de chemokine | |
DE60103052T2 (de) | Verwendung von cxcr4 antagonisten zur behandlung von krebs und autoimmunkrankheiten | |
US6875738B1 (en) | Therapeutic chemokine receptor antagonists | |
KR100898765B1 (ko) | 성장인자 복합체 | |
KR20080082608A (ko) | Vegf 유사체 및 사용 방법 | |
US20090192082A1 (en) | Cxcr4 antagonist treatment of hematopoietic cells | |
JP2009515520A (ja) | 肝細胞成長因子イントロン融合蛋白 | |
KR100682666B1 (ko) | 항혈관형성 단백질 및 이들을 사용하는 방법 | |
DE60106002T2 (de) | Behandlung von hämatopoetischen Zellen mit CXCR4 Agonisten | |
WO2000009152A1 (fr) | Antagonistes therapeutiques du recepteur de la chimiokine | |
JP2018535964A (ja) | 線維芽細胞増殖因子(fgf)1アナログによるステロイド誘導性高血糖の処置 | |
JP2001510988A (ja) | プロテアーゼ活性化受容体3およびその使用 | |
JP2009019032A (ja) | 血管形成及び心臓血管新生の促進又は阻害 | |
KR101008785B1 (ko) | 유사분열촉진 활성을 가진 Bv8 핵산 및 폴리펩티드 | |
WO1997035969A2 (fr) | Ligands peptidiques du recepteur de l'urokinase | |
Spiller et al. | Modulation of human CXCL12 binding properties to glycosaminoglycans to enhance chemotactic gradients | |
US20050164929A1 (en) | Methods of preventing and treating inflammatory bowel disease | |
CA2316405A1 (fr) | Modulation de l'inflammation a l'aide de produits du type protease | |
US20070059314A1 (en) | Novel anti-angiogenic agent and its use in particular within the framework of the treatment of cancer | |
JPH05271291A (ja) | 機能性ポリペプチド | |
CA2307705A1 (fr) | Modulation de l'inflammation a l'aide de produits du type protease | |
KR100568755B1 (ko) | Yh 모티프를 포함하는 펩타이드를 유효성분으로함유하는 혈관신생 억제제 | |
EP2504027B1 (fr) | Accélération de la cicatrisation par un inhibiteur tissulaire des métalloprotéases lié à des ancres de glycosylphosphatidylinositol (gpi) | |
JP2002543784A (ja) | 新規なチンパンジーエリスロポエチン(chepo)ポリペプチドおよびこれをコードする核酸 | |
US20040029775A1 (en) | Methods and compounds for influencing beta3-integrin-dependent intracellular processes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |